A detailed history of Barclays PLC transactions in Opti Nose, Inc. stock. As of the latest transaction made, Barclays PLC holds 49,658 shares of OPTN stock, worth $20,856. This represents 0.0% of its overall portfolio holdings.

Number of Shares
49,658
Previous 49,658 -0.0%
Holding current value
$20,856
Previous $33,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$0.67 - $1.27 $14,453 - $27,396
-21,572 Reduced 30.28%
49,658 $33,000
Q2 2024

Aug 14, 2024

SELL
$0.82 - $1.44 $24,236 - $42,562
-29,557 Reduced 29.33%
71,230 $74,000
Q1 2024

May 15, 2024

SELL
$1.17 - $1.94 $57,318 - $95,040
-48,990 Reduced 32.71%
100,787 $147,000
Q4 2023

Feb 15, 2024

BUY
$1.02 - $1.47 $89,077 - $128,376
87,331 Added 139.85%
149,777 $193,000
Q3 2023

Nov 07, 2023

SELL
$0.93 - $1.38 $1,691 - $2,510
-1,819 Reduced 2.83%
62,446 $77,000
Q2 2023

Aug 03, 2023

BUY
$1.11 - $2.05 $7,429 - $13,720
6,693 Added 11.63%
64,265 $79,000
Q1 2023

May 04, 2023

SELL
$1.63 - $2.02 $29,595 - $36,677
-18,157 Reduced 23.98%
57,572 $111,000
Q4 2022

Feb 13, 2023

BUY
$1.68 - $3.7 $36,247 - $79,831
21,576 Added 39.84%
75,729 $140,000
Q3 2022

Nov 03, 2022

SELL
$3.43 - $4.01 $30,369 - $35,504
-8,854 Reduced 14.05%
54,153 $198,000
Q2 2022

Aug 12, 2022

SELL
$1.76 - $3.82 $7,414 - $16,093
-4,213 Reduced 6.27%
63,007 $231,000
Q4 2021

Feb 14, 2022

SELL
$1.55 - $3.1 $7,861 - $15,723
-5,072 Reduced 7.02%
67,220 $109,000
Q3 2021

Nov 09, 2021

BUY
$2.35 - $3.16 $160,765 - $216,178
68,411 Added 1762.72%
72,292 $217,000
Q2 2021

Aug 13, 2021

SELL
$2.91 - $3.83 $73,841 - $97,186
-25,375 Reduced 86.73%
3,881 $12,000
Q1 2021

May 13, 2021

BUY
$3.47 - $4.75 $62,241 - $85,200
17,937 Added 158.47%
29,256 $107,000
Q4 2020

Feb 11, 2021

SELL
$3.2 - $4.98 $14,598 - $22,718
-4,562 Reduced 28.73%
11,319 $47,000
Q3 2020

Nov 12, 2020

SELL
$3.69 - $7.09 $16,077 - $30,891
-4,357 Reduced 21.53%
15,881 $62,000
Q2 2020

Aug 12, 2020

BUY
$3.58 - $7.44 $28,486 - $59,200
7,957 Added 64.79%
20,238 $151,000
Q1 2020

May 13, 2020

SELL
$3.49 - $9.2 $55,400 - $146,040
-15,874 Reduced 56.38%
12,281 $55,000
Q4 2019

Feb 10, 2020

BUY
$6.27 - $11.41 $94,507 - $171,982
15,073 Added 115.22%
28,155 $260,000
Q3 2019

Nov 14, 2019

SELL
$4.75 - $8.38 $14,178 - $25,014
-2,985 Reduced 18.58%
13,082 $92,000
Q2 2019

Aug 14, 2019

BUY
$6.4 - $10.94 $65,555 - $112,058
10,243 Added 175.88%
16,067 $114,000
Q1 2019

May 15, 2019

BUY
$6.1 - $10.3 $35,526 - $59,987
5,824 New
5,824 $60,000
Q4 2018

Feb 14, 2019

SELL
$5.84 - $11.92 $64,888 - $132,443
-11,111 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$12.43 - $29.76 $53,871 - $128,979
4,334 Added 63.95%
11,111 $138,000
Q2 2018

Aug 14, 2018

BUY
$18.75 - $28.46 $105,937 - $160,799
5,650 Added 501.33%
6,777 $189,000
Q1 2018

May 15, 2018

BUY
$15.91 - $20.82 $4,232 - $5,538
266 Added 30.89%
1,127 $22,000
Q4 2017

Feb 14, 2018

BUY
$15.2 - $20.76 $13,087 - $17,874
861
861 $16,000

Others Institutions Holding OPTN

About OptiNose, Inc.


  • Ticker OPTN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 83,277,504
  • Market Cap $35M
  • Description
  • OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...
More about OPTN
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.